
Icotrokinra demonstrates ‘remarkable’ results in adolescent plaque psoriasis
April 15, 2025 2 min read Key takeaways: Overall, 84.1% and 70.5% of patients treated with icotrokinra achieved IGA 0 or 1 and PASI 90, respectively, by week 16. No new safety signals were identified. New results from a subgroup analysis of the ICONIC-LEAD …